It was reported that the product is not available as the customer is retaining the product.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.A manufacturing record evaluation (mre) review cannot be conducted because no lot number was provided by the customer.Product complaint # (b)(4).
|
This event is associated with a clinical trial, sponsored by biosense webster, inc.It was reported that a (b)(6) male patient (85.7 kg, 71 in) underwent cardiac ablation with thermocool® smart touch¿ bi-directional navigation catheter on (b)(6) 2019 and developed a pericardial effusion.On (b)(6) 2019, procedure day, the patient suffered a pericardial effusion which required a pericardiocentesis.The medical intervention provided was 100 mg of protamine and a closed suction midline chest drain (gravity drainage), 2 units of packed red blood cells (prbc), and a transthoracic echocardiogram (tte).The patient¿s outcome was recovered/resolved and was discharged the next day, (b)(6) 2019.Extended hospitalization was required.The principal investigator assessed this event as moderate in severity, serious, unlikely related to study device (visitag surpoint epu), probably related to study catheters, causally related to study procedure.In the opinion of the principal investigator this event was expected.
|